| Home | My Account | Directories |
Threshold Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results of TH-302 in Patients With Pancreatic Cancer
Published on 2012-02-21 15:24:52
Primary endpoint of Progression Free Survival was met with hazard ratio of 0.61 (p = 0.005). The combination therapy was well tolerated with a safety profile consistent with prior studies. SOUTH SAN FRANCISCO, CA — (CRWENEWSWIRE) -02/21/12- Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) today announced that its 214 patient randomized controlled Phase [Read the Rest...]
Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash
Published on 2012-02-21 15:14:18
MEXICO CITY, Feb. 21, 2012 (CRWENEWSWIRE) — Genomma Lab Internacional, S.A.B. de C.V. (”Genomma”) (BMV:LAB.B.) today announced that it has submitted a non-binding proposal to acquire all of the outstanding shares of Prestige Brands Holdings, Inc. (”Prestige”) (NYSE:PBH) common stock for $16.60 dollars per share in cash. The transaction is valued at approximately $834 million [Read the Rest...]
(CRWE SN, STP, TSL) - Stock Updates! From BestOTC.com
Published on 2012-02-21 10:56:13
Crown Equity Holdings Inc. (CRWE) today announced that it has launched two new online service companies. CRWE Direct and CRWE Real Estate. With expertise in online solutions and marketing, Crown Equity Holdings Inc. has launched CRWE Real Estate (www.crwerealestate.com) to provide a global portal for property listings at a fee of only $1 a day. The [Read the Rest...]
